Conavi Medical Corp. Announces Proposed Public Offering of Units

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES

TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedure, announced today that it has filed a preliminary short form prospectus with the securities regulatory authorities in the Provinces of British Columbia, Alberta and Ontario in connection with an offering of units of the Company (“Units”), with each Unit consisting of one common share and one common share purchase warrant (the “Offering”). The Offering is expected to be completed on a commercially reasonable efforts agency basis pursuant to an agency agreement (the “Agency Agreement”) to be entered into between the Company and Bloom Burton Securities Inc. (“Bloom Burton”) as lead Agent and certain other agents as may be determined (collectively, together with Bloom Burton, the “Agents”). The number of Units to be distributed, the price of each Unit and the exercise price and the expiry date of each warrant will be determined by negotiation between the Company and Bloom Burton in the context of the market with final terms to be determined at the time of pricing.

Read more at globenewswire.com